&lt;p&gt;Nanomedicine, which is blazing new trails in modern healthcare, exploits the distinctive attributes of nanoparticles (NPs) to reimagine diagnosis and therapy. With imaging, this “magic ammunition” enhances the capability of MRI, a noninvasive, high-resolution technology that can pinpoint cancers with astonishing precision. Unlike traditional treatments, which muddle the distinction between diseased and healthy tissue, gold nanoparticles (AuNPs) directly target tumors, using increased permeability and retention (EPR) effects for crystal-clear, early-stage detection. While gadolinium (Gd (III)) T1 agents are the most widely used in clinical practice, iron oxide T2 agents have fallen out of favor due to failing to perform. Beyond imaging, NPs offer a “one-two punch” in the treatment of complicated disorders by enabling photothermal (PTT), photodynamic (PDT), and multimodal therapies (MMT), as well as nano drug delivery systems (NDDS). This nanotechnology-based technique personalizes medicines for diseases such as tuberculosis (TB) and cardiovascular disease (CVD), focusing on damaged tissues to improve therapeutic response. In tuberculosis, NPs circumvent medication resistance by delivering medicines directly to infected cells, thus avoiding biological barriers that impede standard treatments. Similarly, in CVD, NPs target arterial plaques to improve treatment accuracy while reducing systemic adverse effects. Furthermore, the genomic “blueprint” is evolving parallel to nanotechnology, with India's “Genome India” initiative mapping 10,000 genomes, lighting the path for genetic chips suited for specific disorders and moment tests. The convergence of nanotechnology and genomes is an arcade modification, bringing accuracy and personalization to the forefront of cancer and tuberculosis treatment.&lt;/p&gt;

Dinesh Bhatia

Tania Acharjee

Shruti Shukla

Monika Bhatia

AIMS Biophysics

AIMS Biophysics is an international Open Access journal devoted to publishing peer-reviewed, high quality, original papers in the field of biophysics. We publish the following article types: original research articles, reviews, editorials, letters, and conference reports.    AIMS Biophysics welcomes, but not limited to, the papers from the following topics:    · Structural biology  · Biophysical technology  · Bioenergetics  · Membrane biophysics  · Cellular Biophysics  · Electrophysiology  · Neuro-Biophysics  · Biomechanics  · Systems biology

AIMS Biophysics is an international Open Access journal dedicated to publishing peer-reviewed, high-quality original papers in the field of biophysics. We publish various types of articles, including original research articles, reviews, editorials, letters, and conference reports. AIMS Biophysics welcomes papers on a wide range of topics, including but not limited to: structural biology, biophysical technology, bioenergetics, membrane biophysics, cellular biophysics, electrophysiology, neuro-biophysics, biomechanics, and systems biology.

《AIMS Biophysics》是一本国际开放获取期刊，致力于发表经过同行评审的高质量原创论文，涵盖生物物理学领域。我们接受以下类型的文章：原创研究文章、综述、社论、信件和会议报告。《AIMS Biophysics》欢迎但不限于以下主题的论文：结构生物学、生物物理技术、生物能量学、膜生物物理学、细胞生物物理学、电生理学、神经生物物理学、生物力学和系统生物学。

Nano-technological advancements in multimodal diagnosis and treatment

ivySCI AI Smartly Parses PDF, Answers Researchers' Questions, and Helps You Understand Papers in Seconds

Journal Info

Category	Quartile
BIOPHYSICS	4